09.06.2013 Views

ChangingCottonLandscapeNeilForrester

ChangingCottonLandscapeNeilForrester

ChangingCottonLandscapeNeilForrester

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Following is a list of insect tolerance cotton technologies that are likely to be available in the<br />

market in the near term.<br />

1) Monsanto’s Bollgard 3 – Monsanto has recently announced a proposed 2014 global release<br />

date for their new Bollgard 3 product (subject to a favorable regulatory approval process). It will<br />

be a breeding stack of the current Bollgard 2 with the Vip 3A gene to be licensed in from<br />

Syngenta. This should improve the potential durability of the technology from a Resistance<br />

Management perspective and may also enhance the efficacy and range against some<br />

lepidopteran pests.<br />

2) Monsanto’s Lygus bug (sucking insect) tolerance - Monsanto has also announced its work to<br />

develop Lygus bug tolerance which, if successful, will be the first transgenic technology to work<br />

on non-lepidopteran sucking insects. However, highly mobile insects such as the heteropteran<br />

mirids which have damaging adult as well as juvenile stages, will present a real challenge for<br />

insecticidal transgenes which have to be ingested first to work.<br />

3) Bayer’s TwinLink® - Bayer is also developing its own Twin Link 2-gene insect control<br />

technology based on Cry 1Ab and Cry 2Ae from Bacillus thuringiensis. This will be stacked with<br />

the proposed 2-gene stacked Glytol / Liberty Link herbicide tolerant technology.<br />

4) Syngenta’s VipCot® - Syngenta is also close to commercialisation of its 2-gene stacked<br />

VipCot insect control technology based on Cry 1Ab and Vip 3A from Bacillus thuringiensis. The<br />

Cry 1Ab endotoxin protein is very similar to the Cry 1Ab and Cry 1Ac proteins used by all the<br />

other companies but the Vip 3a exotoxin has a unique mode of action and will be a very useful<br />

component for future resistance management programmes for insecticidal transgenic cottons.<br />

However, the recent acquisition of Syngenta’s VipCot commercialisation partner Delta and Pine<br />

Land Company leaves some uncertainty as to the commercial future of this technology.<br />

5) CAMB Bt – CAMB (Centre for Applied Molecular Biology in Lahore) has isolated its own local<br />

versions of Cry 1Ab and Cry 2A from Bacillus thuringiensis and has been granted a patent in<br />

Pakistan in 2005 (Patent # 138279). Commercial agreements have been made with at least one<br />

local company for use of this technology in cotton (both single and double gene variants) and<br />

biosafety studies are proceeding. Backcrossing into elite local cultivars has also started.<br />

There are also a number of other companies/institutes developing various insecticidal<br />

transgenic cottons based on Cry proteins derived from Bacillus thuringiensis, including the<br />

Central Institute for Cotton Research in India (for Gossypium arboreum as well as G. hirsutum)<br />

and NIBGE in Pakistan. An Australian company Hexima is also developing insecticidal<br />

26

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!